ConductScience.org, home

Paper7500751

Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen.

Bloemenkamp KW and 4 others. Lancet, 1995. Cited by 506 papers, by iCite.

Cite this record

ConductScience Library. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen. Papers, record 7500751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7500751

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen.
PubMed
Journal
Lancet
PubMed
Year
1995
PubMed
Publication types
Comment, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
506
iCite
Relative citation ratio, by iCite
18.8
iCite
Revised in PubMed
2019-06-11
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bloemenkamp KWK W
2Rosendaal FRF R
3Helmerhorst FMF M
4Büller HRH R
5Vandenbroucke JPJ P

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Contraceptives, Oral, CombinedMajor topic
Factor VMajor topic
MutationMajor topic
ProgestinsMajor topic
ThrombophlebitisMajor topic
Adolescent
Adult
Desogestrel
Ethinyl Estradiol
Female
Humans
Middle Aged
Risk Factors

Source PubMed

Download CSV of topics

Comments and corrections7

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment in7500743Third-generation oral contraceptives: how risky?https://conductscience.org/library/papers/7500743PubMed
Comment in8596297Safety of combined oral contraceptive pills.https://conductscience.org/library/papers/8596297PubMed
Comment in8596298Safety of combined oral contraceptive pills.https://conductscience.org/library/papers/8596298PubMed
Comment in8596299Safety of combined oral contraceptive pills.https://conductscience.org/library/papers/8596299PubMed
Comment in8598719Factor V Leiden and third-generation oral contraceptives.https://conductscience.org/library/papers/8598719PubMed
Comment in10560680Risk of idiopathic venous thromboembolism in users of progestagens alone.https://conductscience.org/library/papers/10560680PubMed
Comment on7500748
Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
https://conductscience.org/library/papers/7500748PubMed

Download CSV of comments and corrections

Cited by74

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 506 citations.

PMIDTitleJournalYearIn PapersSource
39728272Ischemic Stroke in Women: Understanding Sex-Specific Risk Factors, Treatment Considerations, and Outcomes.J Cardiovasc Dev Dis2024https://conductscience.org/library/papers/39728272PubMed
39358019Beyond Birth Control: The Neuroscience of Hormonal Contraceptives.J Neurosci2024https://conductscience.org/library/papers/39358019PubMed
38707879Evolution of Oral Contraceptive Pills.J Obstet Gynaecol India2024https://conductscience.org/library/papers/38707879PubMed
37612053Cerebral venous sinus thrombosis: changing trends in the incidence, age and gender (findings from the CMC Vellore CVT registry).Stroke Vasc Neurol2024https://conductscience.org/library/papers/37612053PubMed
37235737Hormones and thrombosis: the dark side of the moon.Blood Transfus2024https://conductscience.org/library/papers/37235737PubMed
34956081Combined Oral Contraceptives and Venous Thromboembolism: Review and Perspective to Mitigate the Risk.Front Endocrinol (Lausanne)2021https://conductscience.org/library/papers/34956081PubMed
32551357The French pill scare and the reshaping of social inequalities in access to medical contraceptives.SSM Popul Health2020https://conductscience.org/library/papers/32551357PubMed
32431379Systematic Review of Hormonal Contraception and Risk of Venous Thrombosis.Linacre Q2018https://conductscience.org/library/papers/32431379PubMed
32342502The joint effect of genetic risk factors and different types of combined oral contraceptives on venous thrombosis risk.Br J Haematol2020https://conductscience.org/library/papers/32342502PubMed
31772081Do Norwegian providers comply with national recommendations when prescribing combined oral contraceptives to starters? A cohort study.BMJ Open2019https://conductscience.org/library/papers/31772081PubMed
29388678A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception.Int J Gynaecol Obstet2018https://conductscience.org/library/papers/29388678PubMed
28580443Reduced Prothrombinase Inhibition by Tissue Factor Pathway Inhibitor Contributes to the Factor V Leiden Hypercoagulable State.Blood Adv2017https://conductscience.org/library/papers/28580443PubMed
28202862Venous Thromboembolism Due to Oral Contraceptive Intake and Spending Nights in a Vehicle -A Case from the 2016 Kumamoto Earthquakes.Intern Med2017https://conductscience.org/library/papers/28202862PubMed
28049361Oral Contraceptives and HRT Risk of Thrombosis.Clin Appl Thromb Hemost2018https://conductscience.org/library/papers/28049361PubMed
27975098Endotoxaemia-augmented murine venous thrombosis is dependent on TLR-4 and ICAM-1, and potentiated by neutropenia.Thromb Haemost2017https://conductscience.org/library/papers/27975098PubMed
27642556Suppression of liver Apo E secretion leads to HDL/cholesterol immaturity in rats administered ethinylestradiol.FEBS Open Bio2016https://conductscience.org/library/papers/27642556PubMed
27164970Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women: cohort study.BMJ2016https://conductscience.org/library/papers/27164970PubMed
26500457Family history of venous thromboembolism is a risk factor for venous thromboembolism in combined oral contraceptive users: a nationwide case-control study.Thromb J2015https://conductscience.org/library/papers/26500457PubMed
26149025New insights into the biology of tissue factor pathway inhibitor.J Thromb Haemost2015https://conductscience.org/library/papers/26149025PubMed
24751717Estimate of venous thromboembolism and related-deaths attributable to the use of combined oral contraceptives in France.PLoS One2014https://conductscience.org/library/papers/24751717PubMed

See all 74 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
F52153PubTator's text mininghttps://conductscience.org/library/genes/2153

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7500751

GET https://conductscience.org/api/papers/v1/7500751/cited_by?page=2